Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of topical M512101 in acne vulgaris for 12 weeks
jRCT2080221363Phase 2
- Sponsor
- Maruho Co., Ltd.
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing M512101 with Placebo (2 arms).
02
Drugs
trifarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCT2080221363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221363.